A new vegetable tanning material for leather industry: Acacia nilotica L.

33rd International Union of Leather Technologists and Chemists, IULTCS Congress 2015 -- 24 November 2015 through 27 November 2015 -- 119657Tanning is the most important stage giving the required characteristics to raw materials used in leather industry. Chromium salt is still the most preferred tanning material due to the leather properties of the final products. However, ecological awareness, restrictions and legislations have led the tanners and researchers to seek alternatives to chromium tanning system. Numerous alternatives such as vegetable tannins, titanium, zirconium, aluminum, oxazolidine, starch, silica, polymers, syntans etc. have been investigated to overcome the arising ecological problems. Although there was no fully replacement of chromium salt yet, the tendency is still towards to chromium-less production and the production of metal free leathers. In this study, a new vegetable tanning material extracted from the fruit of Acacia nilotica L. was used in the tanning process of the leather industry. The tannin content, the influence on especially the shrinkage temperature, and final physical properties of leathers such as tensile strength, elongation %, tear strength and color measurements have been investigated. Comparable results with commonly used vegetable tannins were obtained from the extract of Acacia nilotica L. The results showed that the extract of Acacia nilotica L. could be the potential new vegetable tanning material also alternative to metal tanning and other tanning systems for leather industry

Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry

Aims The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Non-ST-segment elevation myocardial infarction (NSTEMI) Registry aims to identify international patterns in NSTEMI management in clinical practice and outcomes against the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without ST-segment-elevation. Methods and results Consecutively hospitalised adult NSTEMI patients (n = 3620) were enrolled between 11 March 2019 and 6 March 2021, and individual patient data prospectively collected at 287 centres in 59 participating countries during a two-week enrolment period per centre. The registry collected data relating to baseline characteristics, major outcomes (inhospital death, acute heart failure, cardiogenic shock, bleeding, stroke/transient ischaemic attack, and 30-day mortality) and guideline-recommended NSTEMI care interventions: electrocardiogram pre- or in-hospital, prehospitalization receipt of aspirin, echocardiography, coronary angiography, referral to cardiac rehabilitation, smoking cessation advice, dietary advice, and prescription on discharge of aspirin, P2Y12 inhibition, angiotensin converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB), beta-blocker, and statin. Conclusion The EORP NSTEMI Registry is an international, prospective registry of care and outcomes of patients treated for NSTEMI, which will provide unique insights into the contemporary management of hospitalised NSTEMI patients, compliance with ESC 2015 NSTEMI Guidelines, and identify potential barriers to optimal management of this common clinical presentation associated with significant morbidity and mortality